Submitted:
07 June 2020
Posted:
07 June 2020
You are already at the latest version
Preprints on COVID-19 and SARS-CoV-2
Abstract
The urgency to develop vaccines against Covid-19 is putting pressure on the long and expensive development timelines which are normally required for development of lifesaving vaccines. There is a unique opportunity to take advantage of new technologies, smart and flexible design of clinical trials, and evolving regulatory science to speed up vaccine development against Covid-19 and transform vaccine development altogether.
Keywords:
COVID-19
; vaccine
; vaccine development
; vaccine discovery
; systems biology
; machine learning
; platform technologies
; adjuvants
; smart clinical trials
; human genetics
; regulatory convergence
; real world evidence
; vaccines safety
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
